Additionally, in silico molecular docking analysis was conducted to identify active phytoconstituents within the extract and their interactions with key NAFLD‐related targets, including PPAR‐α, PPAR‐γ, AMPK, and SREBP‐1c. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.